| Mrs Lashunda Nicole Stephens, FNP | |
|
855 W Broad St Ste A, Athens, GA 30601-2511 | |
| (706) 621-7575 | |
| Not Available |
| Full Name | Mrs Lashunda Nicole Stephens |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 855 W Broad St Ste A, Athens, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467045492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | RN256603 (Georgia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | RN256603 (Georgia) | Primary |
| Entity Name | Tlc Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750677241 PECOS PAC ID: 5496924490 Enrollment ID: O20110809000175 |
News Archive
Life Technologies Corporation a provider of innovative life science solutions, today announced the launch of the 5500xl SOLiD Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.
A report by the Bill & Melinda Gates Foundation that was commissioned by the G20 chair "proposes raising new funding for poorer countries by taxing financial transactions, tobacco, and shipping and aviation fuels, according to details of a G20 report obtained by Reuters," the news service reports.
Neural imaging-maps of brain functions-is a primary tool used by researchers hoping to transform the lives of people living with chronic neurological conditions such as epilepsy. At present, researchers often require several different imaging techniques to fully map brain functions, making research and treatment of these conditions expensive and inefficient.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lashunda Nicole Stephens, FNP 430 Hannah Heights Trl, Hull, GA 30646-3798 Ph: (706) 614-8354 | Mrs Lashunda Nicole Stephens, FNP 855 W Broad St Ste A, Athens, GA 30601-2511 Ph: (706) 621-7575 |
News Archive
Life Technologies Corporation a provider of innovative life science solutions, today announced the launch of the 5500xl SOLiD Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.
A report by the Bill & Melinda Gates Foundation that was commissioned by the G20 chair "proposes raising new funding for poorer countries by taxing financial transactions, tobacco, and shipping and aviation fuels, according to details of a G20 report obtained by Reuters," the news service reports.
Neural imaging-maps of brain functions-is a primary tool used by researchers hoping to transform the lives of people living with chronic neurological conditions such as epilepsy. At present, researchers often require several different imaging techniques to fully map brain functions, making research and treatment of these conditions expensive and inefficient.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
› Verified 3 days ago